Turk Ilac ve Serum Sanayi AS (TRILC) — Cash Flow-to-Debt Ratio
Turk Ilac ve Serum Sanayi AS (TRILC) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of TL44.50 Million could theoretically repay 0% of its total liabilities (TL4.21 Billion) in one year. See Turk Ilac ve Serum Sanayi AS (TRILC) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Turk Ilac ve Serum Sanayi AS Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Turk Ilac ve Serum Sanayi AS across 7 annual periods. Also explore net asset growth rate of Turk Ilac ve Serum Sanayi AS to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Turk Ilac ve Serum Sanayi AS (2018–2024)
Year-by-year debt coverage analysis for Turk Ilac ve Serum Sanayi AS. For market capitalisation and broader financial context, see TRILC market cap.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.18x | TL-378.48 Million | TL2.07 Billion | ▼ -146.8% |
| 2023 | 0.39x | TL408.19 Million | TL1.04 Billion | ▲ +1678.4% |
| 2022 | -0.02x | TL-11.88 Million | TL479.65 Million | ▲ +89.8% |
| 2021 | -0.24x | TL-71.67 Million | TL295.46 Million | ▼ -283.4% |
| 2020 | 0.13x | TL33.20 Million | TL250.99 Million | ▲ +100.5% |
| 2019 | 0.07x | TL13.32 Million | TL201.84 Million | ▼ -78.0% |
| 2018 | 0.30x | TL38.13 Million | TL127.38 Million | — |